• Sweet Earth (SE) has signed a letter of intent with an investment consortium to launch a German online shopping portal
  • The consortium deals in German brands, global consulting and agricultural products for the European Union
  • Work on a German online shopping portal has already commenced
  • Sweet Earth Holdings is a farm-to-shelf hemp grower with a full line of hemp and CBD products for the U.S. and global market
  • Sweet Earth (SE) is down 3.28 per cent and is currently trading at C$0.295 per share

Sweet Earth (SE) has signed a letter of intent with an investment consortium to launch a German online shopping portal.

The consortium runs businesses in Spain and Germany associated with German brands, global consulting and agricultural products for the European Union.

Sweet Earth and the consortium will create a joint venture to sell the company’s products online and through retail outlets. Work on a German online shopping portal has already commenced.

In order to facilitate smooth importation into Germany, Sweet Earth will bulk manufacture its products in the United States. Upon importation into the EU, the consortium will transport the products to its Hamburg facility where they will be blended with EU-approved CBD, packaged and sold under the Sweet Earth CBD brand online and through retail. 

Initial product shipments will commence in lots of approximately 1,000 and will include Sweet Earth Organic CBD Hydration Cream, Sweet Earth Organic CBD Lip Balm, Sweet Earth CBD Muscle Recovery Rub and Sweet Earth Organic CBD Salve.

In addition, the consortium will sell Sweet Earth products on its own shopping portal along with other CBD products.

Sweet Earth Holdings is a vertically integrated farm-to-shelf hemp grower that maintains a full line of hemp and CBD products for the U.S. and global market.

Sweet Earth (SE) is down 3.28 per cent and is currently trading at C$0.295 per share as of 3:15 pm EST.

More From The Market Online

Tilray Brands seeks US$250M for U.S. cannabis expansion

Global cannabis stock Tilray Brands (TSX:TLRY) intends to raise up to US$250 million to fund its U.S. expansion plan.

The Market Online’s Weekly Cannabis Report – May 17, 2024

This international biopharmaceutical company revealed it has completed the retrospective observational real-world evidence study.

Avicanna finishes study of CBD cream’s use for rare skin disorder

Avicanna (TSX:AVCN) completes an observational study of its RHO Phyto-branded Ultra CBD topical cream on patients with epidermolysis bullosa.